MarketResearchFuture.com published a Half-Cooked research report on “ME&A Nasal Drug Delivery Market Research Report – Forecast to 2022” reports to its database. – Market Analysis, Scope, Stake, Progress, Trends and Forecast to 2022.
TRY SAMPLE REPORT @ https://www.marketresearchfuture.com/sample_request/2696 .
Taking all factors into consideration, we expect the Middle East and Africa nasal drug delivery market to reach around $ 1.59 billion in 2022 growing at a CAGR of 8.1%; this market was worth $ 1 billion in 2015.
The report titled “Nasal Drug Delivery Market -Forecast to 2022″ is a direct appreciation by Market Research Future of the market potential of the Nasal Drug Delivery Market. The report intends to provide accurate and meaningful insights, both quantitative as well as qualitative. It can be said with high confidence level, that this report will satisfy the need for comprehensive insights needed to compete and beat other players in today’s winner takes all market!
Geographically, nasal drug delivery market is segmented into four key regions: the Americas, Europe, Asia Pacific, and the Middle East & Africa. The Americas is further segmented into North America and South America. And North America is segmented into the U.S. and Canada. ME&Aly, the US is the largest market for Nasal Drug Delivery owing to increasing incidence of asthma and chronic obstructive pulmonary disease (COPD), growing preference for nasal drug delivery, growing adoption for self-administration, and increasing need for technological advancements. Similarly, increasing healthcare spending is likely to grow the demand for nasal drug delivery market. Similarly, according to CMS (Centres for Medicare and Medicaid Services) U.S. health care spending increased 4.3 percent to reach USD 3.3 trillion per person in 2016.
Europe accounts for the second largest market due to advanced technology, new product innovation, growing prevalence of chronic obstructive pulmonary disease, and rising healthcare expenditure. For instance according to Eurostat, Germany incurred healthcare expenditure of over EUR 321 billion in the year 2014. According to a recent survey around 1,410 people died of asthma in UK. Additionally, National Health Services spends around USD 1 billion yearly for treatment of asthma.
Asia pacific region is expected to be fastest growing region in nasal drug delivery market owing to its growing population and increasing healthcare expenditure and demand for new treatment options fuel the market growth.
On the other hand, the Middle East & Africa is expected to witness limited growth due to limited access to the healthcare resources and lack of awareness about rare diseases. In the Middle East, the growth of the market is driven by increasing availability new diagnostic and treatment methods.
Key Market Players:
There are various market players operating in the ME&A nasal drug delivery market. Some of the key market players in this market are: Becton, Dickinson and Company, OptiNose US Inc., Bespak Europe Ltd, Kurve Technology, Inc., AstraZeneca Plc, Teleflex Medical Europe Ltd., AptarGroup, Inc., Procter & Gamble, GlaxoSmithKline plc, and Janssen ME&A Services, LLC.
Founded on 1992, headquartered at U.K., AstraZeneca, is a biopharmaceutical company that is engaged in the discovery and development of prescriptive medicines. The firm offers its medicines in three therapeutic areas such as oncology, cardiovascular & metabolic diseases and respiratory. The firm operates in over 100 countries. The company has focused on various inorganic and organic growth strategies to enhance its product portfolio and gain foothold in various geographies. For instance in the year 2017, AstraZeneca received US Food and Drug Administration (FDA) approval for its Fasenra product. This product aids in the treatment of patients with severe asthma. Additionally, in 2016, AstraZeneca entered into an agreement with Cilag GmbH International to distribute Rhinocort Aqua, outside the U.S. These product approvals and agreements increases the firm’s customer base and widens the company’s already existing wide product portfolio.
Headquartered at Berlin, Germany, the firm offers products for various therapeutic areas such as oncology, hematology, cardiology, women’s health and ophthalmology. The firm offers its products all over the world. The firm has focused on various growth strategies such as expansions, product launches, acquisition and collaboration to enhance its product portfolio and widen its foothold in various geographies. For instance in 2017 Bayer AG launched hydraSense, a daily nasal care. Additionally in 2014, Bayer AG acquired consumer care business from Merck & Co. This acquisition enhances Bayer’s over the counter business across different geographies.
ME&A Nasal Drug Delivery Market – Overview:
Nasal Drug Delivery is a route of drug administration, which provides a direct access to systemic circulation. Nasal administration provides various advantages such as rapid absorption, ease of self-administration, good patient compliance, lower dose and lower side effects, use friendly and non-invasive as compared to other modes of drug administration.
The market for nasal drug delivery is growing a healthy growth due to a host of factors such as increasing focus on alternative routes of drug delivery, easy administration & better efficacy, growing self-administration practices, and growing incidence of chronic diseases. Additionally, growth strategies such as new product innovation, large pipeline products, and merger & acquisition activities taken up major market players are likely to enhance the growth of nasal drug delivery market.
According to American Academy of Allergy Asthma & Immunology, prevalence of asthma is likely to grow by 100 million by 2025.This rising case of asthma is likely to enhance the growth of nasal drug delivery market.
However, factors such as complications associated with the overuse of nasal sprays and the risk of local side effects are likely to hamper the growth of nasal drug delivery market.
Middle East and Africa nasal drug delivery market has been segmented on the basis of dosage form which comprises of drops, sprays, powder, gels and ointments. On the basis of system, market is segmented into unit dose, multi-dose and metered dose. On the basis of delivery technologies; market is segmented into spray, nebulizers and other. On the basis of therapeutic applications; market is segmented into rhinitis, congestion, vaccinations and others.
Major Table of Contents:
Chapter 1. Introduction
1.2 Scope Of Study
1.3 Research Objective
1.4 Assumptions & Limitations
1.5 Market Structure:
Chapter 2. Research Methodology
2.1 Research Process
2.2 Primary Research
2.3 Secondary Research
Chapter 3. Market Dynamics
3.5 Macroeconomic Indicators
Chapter 4. Market Factor Analysis
4.1 Porter’s Five Forces Model
4.1.1 Bargaining Power Of Suppliers
4.1.2 Bargaining Power Of Customer
4.1.3 Intensity of Competitor’s
4.1.4 Threat Of New Entrants
Chapter 5. Middle East and Africa Nasal Drug Delivery Market, By Dosage Form
5.1.4 Gels and Ointments
AVAIL AMAZING DISCOUNT ON REPORT @ https://www.marketresearchfuture.com/check-discount/2696 .
About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune – 411028
+1 646 845 9312